Teva Pharmaceutical Industries Ltd. Company Profile
Teva Pharmaceutical Industries Ltd
Pharmaceutical Industry
- Type
Public
- Headquarters
Israel
- Founded
1901
- Key Management
Mr. Kåre Schultz (CEO)
- Revenue
~15,878 (2021)
- Headcount
~37,537 (2021)
- Website
Business Description
Teva Pharmaceutical Industries Ltd. is involved in the development and manufacture of medicines. It produces medicines for heart disease, pain relief, obesity, cancer, supportive care, infectious diseases, and human immunodeficiency virus. The company operates in the following geographic segments: North America and Europe. The company was established in Petah Tikva in Israel in 1901.
Key Financials
Revenue (US$ Mn):
- US$ 15,878 Mn was the annual revenue generated by Teva Pharmaceutical Industries Ltd. in 2021
- Teva Pharmaceutical Industries Ltd.’s annual revenue for 2020 was US$ 16,658 Mn, a -1.36% decrease from 2019
- From 2018’s annual revenues, Teva Pharmaceutical Industries Ltd. registered a -10.43% decrease in 2019, amounting to US$ 16,887Mn
- Total revenue of US$ 18,854 Mn was generated in 2018 by Teva Pharmaceutical Industries Ltd.
Operating Income (US$ Mn):
- Teva Pharmaceutical Industries Ltd.’s operating income for 2021 was US$ 1,716 Mn, a -43.88% decrease from 2020
- The operating income generated by Teva Pharmaceutical Industries Ltd. in 2020 was US$ 3,058 Mn
- At a -5.16% decrease, Teva Pharmaceutical Industries Ltd.’s operating income of US$ 2,721 Mn was indexed in 2019
- Teva Pharmaceutical Industries Ltd. generated an operating income of US$ 2,869 Mn in 2018
Net Income (US$ Mn):
- US$ 417 Mn was the net income generated by Teva Pharmaceutical Industries Ltd. in 2021
- Teva Pharmaceutical Industries Ltd.’s net income for 2020 was US$ -3,990 Mn, a 299.4% increase from 2019
- From 2018’s net incomes, Teva Pharmaceutical Industries Ltd. registered a -53.53% decrease in 2019, amounting to US$ -999 Mn
- A net income of US$ -2,150 Mn was generated in 2018 by Teva Pharmaceutical Industries Ltd.
Operating Margin %:
- Teva Pharmaceutical Industries Ltd.’s operating margin for 2021 was 11%, a -41.3% decrease from 2020
- The operating margin generated by Teva Pharmaceutical Industries Ltd. in 2020 was 18%
- At a 5.92% increase, Teva Pharmaceutical Industries Ltd.’s operating margin of 16% was indexed in 2019
- Teva Pharmaceutical Industries Ltd. generated an operating margin of 15% in 2018
Gross Margin %:
- 48% was the gross margin generated by Teva Pharmaceutical Industries Ltd. in 2021
- Teva Pharmaceutical Industries Ltd.’s gross margin for 2020 was 46%, a 4.04% increase from 2019
- From 2018’s gross margins, Teva Pharmaceutical Industries Ltd. registered a 1.36% increase in 2019, amounting to 45%
- A gross margin of 44% was generated in 2018 by Teva Pharmaceutical Industries Ltd.
SWOT Analysis
Strengths
Leading position in the global generics industry
Teva Pharmaceutical Industries Ltd. is involved in the development and manufacture of medicines. It produces medicines for heart disease, pain relief, obesity, cancer, supportive care, infectious diseases, and human immunodeficiency virus. The company operates in the following geographic segments: North America and Europe. The company was established in Petah Tikva in Israel in 1901.
Get this premium content
